Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH:ubiquinone oxidoreductase subunit A3 pseudogene 2 (NDUFA3P2)
- Target
- NDUFA3P2
- Molecular classification
- Other (Pseudogene, not a member of any receptor, enzyme, channel, or transporter family)
01
Overview
NDUFA3P2 is annotated as a pseudogene in the human genome and does not encode a functional protein[1]. It is homologous to NDUFA3, a protein-coding gene involved in mitochondrial electron transport, but NDUFA3P2 itself lacks coding potential due to mutations or structural truncations that prevent translation[1]. Pseudogenes like NDUFA3P2 may be remnants of evolutionary duplication events or gene decay and generally do not participate in biological processes or pathways. Accordingly, NDUFA3P2 is not a therapeutic target, is not involved in disease, and does not interact with drugs. If the intention was to reference an active mitochondrial enzyme or subunit (for example, NDUFA3, not NDUFA3P2), more specific and accurate information should be provided regarding the correct functional protein[5].
- Other names
- NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3 pseudogene 2NDUFA3P2NADH:ubiquinone oxidoreductase subunit A3 pseudogene 2
Beyond the preview
Go deeper on NADH:ubiquinone oxidoreductase subunit A3 pseudogene 2 (NDUFA3P2).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NADH:ubiquinone oxidoreductase subunit A3 pseudogene 2 (NDUFA3P2).